COMMUNIQUÉS West-GlobeNewswire

Eurobio Scientific: COMMUNIQUÉ DU 24 SEPTEMBRE 2026 RELATIF AU DEPÔT D’UNE OFFRE PUBLIQUE DE RETRAIT SUIVIE D’UN RETRAIT OBLIGATOIRE VISANT LES ACTIONS DE LA SOCIÉTÉ
24/09/2026
COMMUNIQUÉ DU 24 SEPTEMBRE 2026 RELATIF AU DEPÔT D’UNE OFFRE PUBLIQUE DE RETRAIT SUIVIE D’UN RETRAIT OBLIGATOIRE VISANT LES ACTIONS DE LA SOCIÉTÉ INITIEE PAR EB DEVELOPMENT PRESENTEE PAR CIC BANQUE PRESENTATRICE ET [...]
Grant of Restricted Stock Units and Warrants to Employees in Genmab
24/09/2026
Company Announcement COPENHAGEN, Denmark; September 24, 2026 – Genmab A/S (Nasdaq: GMAB) announced today that the Board of Directors decided to grant 13,794 restricted stock units and 13,331 warrants to employees of the [...]
Embark Behavioral Health Releases 2025 Outcomes Report Highlighting Measurable Improvements for Youth Mental Health
24/09/2026
Embark’s new data from more than 3,000 admissions in 2025 shows meaningful reductions in depression, anxiety and distress, along with gains in overall well-being, based on validated clinical assessments completed [...]
PROLLENIUM® Spotlights the Future of Regenerative Aesthetics at Aesthetic Next 8.0 and Chateau Prollenium Dallas
24/09/2026
RICHMOND HILL, Ontario, Sept. 24, 2026 (GLOBE NEWSWIRE) -- PROLLENIUM ® , a global leader in aesthetic innovation, brought clinical education, regenerative aesthetics and injectable technique to Dallas through two [...]
Healthcare’s Challenges Have Changed. MGMA’s Purpose Has Not.
24/09/2026
MGMA celebrates 100 years of helping medical practice leaders turn shared challenges into practical solutions Englewood, Colorado and San Antonio, Texas, Sept. 24, 2026 (GLOBE NEWSWIRE) -- Workforce shortages. Financial [...]
Prime Medicine Announces U.S. FDA Clearance of Investigational New Drug Application for PM647 in Alpha-1 Antitrypsin Deficiency
24/09/2026
-- Clearance highlights continued execution, modularity and momentum across Prime Medicine’s liver franchise, building on recent regulatory clearances for PM577a -- -- Initial clinical data expected in 2027 -- CAMBRIDGE [...]
Hemab Therapeutics Strengthens Board of Directors with Appointment of Keli Walbert
24/09/2026
Keli Walbert brings two decades of commercial leadership and proven track record of successful launches to the Board CAMBRIDGE, Mass. and COPENHAGEN, Denmark, Sept. 24, 2026 (GLOBE NEWSWIRE) -- Hemab Therapeutics ( [...]
Rezolute Reports Fourth Quarter and Full Year Fiscal 2026 Financial Results and Provides Business Update
24/09/2026
REDWOOD CITY, Calif., Sept. 24, 2026 (GLOBE NEWSWIRE) -- Rezolute, Inc. (Nasdaq: RZLT) (“Rezolute” or the “Company”), a late-stage ultra-rare rare disease company focused on treating refractory hypoglycemia caused by [...]
Mineralys Therapeutics to Participate in the Stifel 2026 Virtual Cardiometabolic Forum
24/09/2026
RADNOR, Pa., Sept. 24, 2026 (GLOBE NEWSWIRE) -- Mineralys Therapeutics, Inc. (Nasdaq: MLYS), a biopharmaceutical company focused on developing medicines to target hypertension and aldosterone-related adverse outcomes in [...]
Regeneron to Report Third Quarter 2026 Financial and Operating Results and Host Conference Call and Webcast on October 30, 2026
24/09/2026
TARRYTOWN, N.Y., Sept. 24, 2026 (GLOBE NEWSWIRE) -- Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN ) today announced that it will report its third quarter 2026 financial and operating results on Friday, October 30, 2026 [...]
Buckingham Psychiatry Welcomes Psychologist Dr. Sophie Buinewicz
24/09/2026
The Bucks County-Based Mental Health Practice Introduces a Licensed Clinical Psychologist to Its Team DOYLESTOWN, Pa. and LAMBERTVILLE, N.J., Sept. 24, 2026 (GLOBE NEWSWIRE) -- Buckingham Psychiatry, serving patients in [...]
Spectral AI Announces Upcoming Presentation at ACS Clinical Congress 2026 Highlighting the Use of Artificial Intelligence and Multi-Spectral Imaging in the Assessment of Burn Wounds
24/09/2026
DALLAS, Sept. 24, 2026 (GLOBE NEWSWIRE) -- Spectral AI, Inc. (Nasdaq: MDAI) (“Spectral AI” or the “Company”) , an artificial intelligence (AI) company focused on medical diagnostics for faster and more accurate [...]
NANOBIOTIX fait le point sur ses activités et ses résultats financiers du premier semestre 2026
24/09/2026
Résultats préliminaires prometteurs issus de l’analyse complète des cohortes dans les parties escalade et expansion de dose d’une étude achevée de phase 1 évaluant JNJ-1900 (NBTXR3) chez des patients atteints d’un [...]
NANOBIOTIX Provides First Half 2026 Operational and Financial Update
24/09/2026
Promising early results reported from full cohort analysis of the completed dose-escalation and expansion phases of a Phase 1 study evaluating JNJ-1900 (NBTXR3) for patients with inoperable, locoregionally recurrent non [...]
Clover Health Welcomes Former U.S. Senator Robert Torricelli and MedPAC Commissioner Dr. Brian J. Miller M.D. to Its Board of Directors
24/09/2026
WILMINGTON, Del., Sept. 24, 2026 (GLOBE NEWSWIRE) -- Clover Health Investments, Corp. (Nasdaq: CLOV) (“Clover,” “Clover Health” or the “Company”) today announced the appointments of former U.S. Senator Robert Torricelli [...]
UPDATE – Clover Health Welcomes Former U.S. Senator Robert Torricelli and Dr. Brian J. Miller M.D. to Its Board of Directors
24/09/2026
WILMINGTON, Del., Sept. 24, 2026 (GLOBE NEWSWIRE) -- Clover Health Investments, Corp. (Nasdaq: CLOV) (“Clover,” “Clover Health” or the “Company”) today announced the appointments of former U.S. Senator Robert Torricelli [...]
CORRECTION – Free Family Fun Night in Cedar Park: Ally Medical ER Ribbon Cutting
24/09/2026
Ally Medical ER Cedar Park hosts an evening of free food, drinks, giveaways, and kid-friendly games on October 1st. CEDAR PARK, Texas, Sept. 24, 2026 (GLOBE NEWSWIRE) -- In a release issued under the same headline [...]
Eurobio Scientific: Results for the first semester of fiscal year 2026
24/09/2026
RESULTS FOR THE FIRST SEMESTER OF FISCAL YEAR 2026 Revenue up 4.5% to 84.5 M€ Proprietary products account for 37% of revenue 46% of revenue generated outside France Free cash flow of €4 million after investments Net [...]
Eurobio Scientific: Résultat du 1er semestre 2026
24/09/2026
RESULTAT DU 1 ER SEMESTRE 2026 Chiffre d’affaires en croissance de 4,5% à 84,5 M€ les produits propriétaires atteignent 37% du CA la part du CA hors France est de 46% Flux de trésorerie disponible de 4 M€ après [...]

Pages